Selected article for: "activation neutrophil and acute respiratory distress syndrome"

Author: Tomar, Bhawna; Anders, Hans-Joachim; Desai, Jyaysi; Mulay, Shrikant R.
Title: Neutrophils and Neutrophil Extracellular Traps Drive Necroinflammation in COVID-19
  • Cord-id: 6ri6bxfc
  • Document date: 2020_6_2
  • ID: 6ri6bxfc
    Snippet: The COVID-19 pandemic is progressing worldwide with an alarming death toll. There is an urgent need for novel therapeutic strategies to combat potentially fatal complications. Distinctive clinical features of severe COVID-19 include acute respiratory distress syndrome, neutrophilia, and cytokine storm, along with severe inflammatory response syndrome or sepsis. Here, we propose the putative role of enhanced neutrophil infiltration and the release of neutrophil extracellular traps, complement act
    Document: The COVID-19 pandemic is progressing worldwide with an alarming death toll. There is an urgent need for novel therapeutic strategies to combat potentially fatal complications. Distinctive clinical features of severe COVID-19 include acute respiratory distress syndrome, neutrophilia, and cytokine storm, along with severe inflammatory response syndrome or sepsis. Here, we propose the putative role of enhanced neutrophil infiltration and the release of neutrophil extracellular traps, complement activation and vascular thrombosis during necroinflammation in COVID-19. Furthermore, we discuss how neutrophilic inflammation contributes to the higher mortality of COVID-19 in patients with underlying co-morbidities such as diabetes and cardiovascular diseases. This perspective highlights neutrophils as a putative target for the immunopathologic complications of severely ill COVID-19 patients. Development of the novel therapeutic strategies targeting neutrophils may help reduce the overall disease fatality rate of COVID-19.

    Search related documents:
    Co phrase search for related documents
    • accessory protein and acute mers cov respiratory syndrome coronavirus: 1, 2
    • accessory protein and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • accessory protein and lung infection: 1
    • ace inhibitor and acute ards respiratory distress syndrome: 1, 2, 3, 4
    • ace inhibitor and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • ace inhibitor and lung affect: 1, 2, 3, 4, 5
    • ace inhibitor and lung infection: 1
    • ace inhibitor and lung inflammation: 1
    • activate neutrophil and acute ards respiratory distress syndrome: 1
    • activate neutrophil and acute respiratory syndrome: 1, 2
    • activate neutrophil and lung infiltration: 1
    • activate neutrophil and lung infiltration neutrophil: 1
    • activate neutrophil and lung neutrophil infiltration: 1
    • acute ards respiratory distress syndrome and lung infiltration: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21
    • acute ards respiratory distress syndrome and lung infiltration neutrophil: 1, 2, 3, 4
    • acute ards respiratory distress syndrome and lung inflammation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute ards respiratory distress syndrome and lung neutrophil infiltration: 1, 2, 3, 4
    • acute ards respiratory distress syndrome and lymphocyte high neutrophil: 1, 2
    • acute ards respiratory distress syndrome and lymphocyte neutrophil: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25